Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 03-2020 | 03-2019 | 03-2018 | 03-2017 | |
| Sales | 1,090 | 0 | 0 | 0 | 1,250 |
| Gross Profit | 1,090 | N/A | N/A | N/A | 1,250 |
| Operating Expenses | 19,023 | 20,802 | 24,556 | 14,200 | 11,499 |
| Operating Income | -17,934 | -20,802 | -24,556 | -14,200 | -10,249 |
| Interest Expense | 0 | -30 | 8 | 9 | 5 |
| Other Income | 2 | 0 | -23 | -135 | 0 |
| Pre-tax Income | -17,932 | -20,771 | -24,587 | -14,344 | -10,253 |
| Income Tax | 3 | 3 | 3 | 2 | 2 |
| Net Income Continuous | -17,934 | -20,774 | -24,590 | -14,346 | -10,256 |
| Net Income | $-17,934 | $-20,774 | $-24,590 | $-14,346 | $-10,256 |
| EPS Basic Total Ops | -14.71 | -15.02 | -27.03 | -33.63 | -46.25 |
| EPS Basic Continuous Ops | -6.25 | -14.22 | -25.85 | -31.02 | -40.89 |
| EPS Diluted Total Ops | -14.71 | -15.02 | -27.03 | -33.63 | -46.25 |
| EPS Diluted Continuous Ops | -6.25 | -14.22 | -25.85 | -31.02 | -40.89 |
| EPS Diluted Before Non-Recurring Items | -14.72 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-17,816 | $-20,685 | $-24,345 | $-14,119 | $-10,110 |